China Medical Robot Industry Report, 2020-2026
-
Jul.2020
- Hard Copy
- USD
$3,400
-
- Pages:165
- Single User License
(PDF Unprintable)
- USD
$3,200
-
- Code:
ZLC112
- Enterprise-wide License
(PDF Printable & Editable)
- USD
$4,800
-
- Hard Copy + Single User License
- USD
$3,600
-
Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (up by 50% YoY) in 2018.
Medical robot grows fastest in the US. As of March 31, 2020, Intuitive Surgical has installed 5,669 units of Da Vinci surgical system in all worldwide, including 3,581 units in the US, or 63.2% of the total.
China’s intelligent medical robot industry started later than its foreign peers. In current stage, the whole industry is in a transitional phase from research and development and clinical trials to commercialization and mass production. In 2019, China’s medical robot market was worth $620 million.
Rehabilitation robot has been the largest segment in China’s medical robot market thanks to a combination of positive factors such as broad application and favorable policies, sweeping 42.9% of the market in 2019. Surgical robot makes slow progress in promotion and holds a small share due to high application cost, albeit an upsurge at the early stage.
Of the nearly 100 medical robot companies in China, most are still in infancy. The rosy prospect of medical robot fuels investment enthusiasm. From the financing cases in recent years, it can be seen that companies with clear timetable of product launch or certified by the CFDA, are favored by capital. Players such as Remebot, HOZ Medical, Scream Intelligent Technology, Taimi Robotics Technology, Borns Medical Robotics, Ankon Technologies and Tinavi Medical Technologies even raised more than RMB100 million in their funding rounds.
In the Chinese medical robot market, the ever deeper university-industry-research cooperation stimulates the industry. Companies of industrial robots and medical devices branch out to the intelligent medical robot field progressively with many years of technical expertise, and has collaborations with domestic research institutes at multiple levels; research institutes otherwise market their research results by incubating companies.
Furthermore, COVID-19 pandemic props up demand for medical robots. During the time, hospitals as the battlefront used intelligent medical robots for guide, disinfection and sterilization.
In future, population aging and other factors will animate China’s medical robot market which will be worth $2.49 billion in 2026.
China Medical Robot Industry Report, 2020-2026 highlights the following:
Development environment for China medical robot industry (global market, economic environment and policy climate);
Development of China medical robot industry (status quo, market size, market structure, competitive landscape, market segments and development trends);
Global and Chinese companies (operation and medical robot business).
1. Medical Robotics
1.1 Definition
1.1.1 Robotics
1.1.2 Medical Robot
1.2 Industry Chain
2. Operation Environment of Medical Robot in China
2.1 Global Market
2.1.1 Status Quo
2.1.2 Competition Pattern
2.2 Economic Environment
2.3 Policies
3. Medical Robot in China
3.1 Overview
3.2 Market Size
3.3 Market Structure
3.4 Competition Pattern
3.5 Market Segments
3.5.1 Rehabilitation Medical Robot
3.5.2 Surgical Robotics
3.5.3 Orthopedic Surgery Robotics
3.5.4 Pharmacy Robotics
3.6 Development Trends
3.6.1 Industry-University-Research Collaboration Brings Life to Development
3.6.2 The Demand for Medical Robot Soars amid COVID-19 Pandemic
3.6.3 VC Investments Facilitates the Medical Robot Industry
3.6.4 Medical Robot Finds Ever More Clinical Application
3.6.5 Novel Robotics Springs up like Single Port Access Surgery Robot, Nanostructure Target Robot, and Flexible Robot
3.6.6 Regulation on Products Gets Tightened
4. Major Medical Robot Companies Worldwide
4.1 Intuitive Surgical, Inc.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R&D Cost
4.1.6 Development in China
4.2 Stryker Corporation
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 R&D Cost
4.2.6 Medical Robot Business
4.3 Ekso Bionics Holdings, Inc.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D Cost
4.4 ReWalk Robotics Ltd.
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D Cost
4.5 Rex Bionics Plc
4.6 Mazor Robotics Ltd.
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D Cost
4.7 Johnson & Johnson
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 R&D Cost
4.7.6 Medical Robot Business
4.8 Avatera Medical
4.9 CMR Surgical
4.10 MedRobotics Corp
4.11 Medtronic
4.11.1 Profile
4.11.2 Operation
4.11.3 Medical Robot Business
4.12 Meerecompany
4.12.1 Profile
4.12.2 Operation
4.12.3 Medical Robot Business
4.13 Titan Medical
4.13.1 Profile
4.13.2 Operation
4.13.3 Medical Robot Business
4.14 TransEnterix
4.14.1 Profile
4.14.2 Operation
4.14.3 Medical Robot Business
5. Major Medical Robot Enterprises in China
5.1 Shenyang SIASUN Robot & Automation Co., Ltd.
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Medical Robot Business
5.1.6 Development Prospect & Forecast
5.2 Guangdong Jinming Machinery Co., Ltd.
5.2.1 Profile
5.2.2 Operation
5.2.3 Medical Robot Business
5.3 Midea Group Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Medical Robot Business
5.4 Truking Technology Limited
5.4.1 Profile
5.4.2 Operation
5.4.3 Medical Robot Business
5.5 Chongqing Dima Industry Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Medical Robot Business
5.6 Jinho Robot (Shanghai) Co., Ltd.
5.7 Shenzhen Mai Kangxin Medical Co., Ltd.
5.8 Henan Huibo Shenfang Intelligent Rehabilitation Equipment Co., Ltd.
5.9 TINAVI Medical Technologies Co., Ltd.
5.9.1 Profile
5.9.2 Operation
5.9.3 Medical Robot Business
5.10 Harbin Boshi Automation Co., Ltd.
5.10.1 Profile
5.10.2 Operation
5.10.3 Medical Robot Business
5.11 Remebot
5.12 Smart Robot Technology Group Co., Ltd.
5.13 Jinshan Science & Technology (Group) Co., Ltd
5.13.1 Proflie
5.13.2 Medical Robot Business
5.14 Taimi Robotics Technology Co., Ltd.
5.14.1 Profile
5.14.2 Medical Robot Business
5.15 ANKON Technologies Co., Ltd.
5.15.1 Profile
5.15.2 Operation
5.15.3 Medical Robot Business
5.16 Shenzhen Weibond Technology Co., Ltd.
5.17 Shenzhen Sanggu Medical Robot Co., Ltd.
5.18 Wuxi Anzhizhuo Medical Robot Co., Ltd.
Classification of Medical Robot and Major Companies
Cost Structure of Robotics
Industrial Chain of Service Robotics
Core Modules and Technologies of Service Robotics
Enterprise Pattern of Global Service Robotics Industry
Global Service Robotics Market Size and Growth Rate, 2013-2020
Global Service Robotics Market Share (by Application), 2019
Global Medical Service Robotics Market Size and Growth Rate, 2019-2026E
Percentages for Cumulative Installations of Intuitive Surgical’s Da Vinci Robot Worldwide (by Region) as of March 31, 2020
Leading Competitors in Global Medical Robot Industry
Acquisitions in Global Medical Robot Industry over the Recent Years
Per Capita Disposable Income of Chinese Residents, 2013-2019
China’s Policies on Medical Robot
Development Status Quo of Medical Robot (by Type) in China
Number of Patents about China-made Medical Robot
China Service Robotics Market Size and YoY Change, 2013-2020
China Medical Robot Market Size and YoY Change, 2016-2026E
China Medical Robot Market Structure, 2019
Leading Manufacturers of Medical Service Robotics in China
Competition Pattern of Intelligent Medical Service Robots in China
Classification of Rehabilitation Robots
Major Chinese Manufacturers of Rehabilitation Robot
China’s Population Aged over 60 and % of Total Population, 2009-2025
Number of Workers Aged 16-59 as a Percentage of Total Population in China, 2010-2019
Average Family Size in China, 2009-2019
Disabled Population’ Proportion in China’s Total by Type, 2018
Education of the Disabled in China as of End-2018
Employment of the Disabled in China as of End-2019
Policies for the Disabled in China, 2019
Surgical Robots that Passed FDA and CFDA Certifications in Early Stage
The Approved (by FDA) Types of Operation by Da Vinci Robot
Cumulated Installations of Da Vinci Robots Worldwide, 2012-2019
Yearly Installations of Da Vinci Robots, 2012-2019
Yearly Operations by Global Da Vinci Robots and YoY Change, 2012-2019
Price Comparison of Da Vinci Robots in China and the United States ($10,000)
Top 5 Hospitals by Da Vinci Robot Installations in China as of End-2018
Top 10 Hospitals by Operations Per Robot in China, 2018
Top 10 Hospitals by Da Vinci Robot Thoracic Surgery in China, 2018
Main Surgical Robot Companies and Products in China
Statistics on Operations Assisted by Orthopedic Surgery Robot of TINAVI Medical Technologies as of End-2019
Statistics on Industry-University-Research Collaborations in Intelligent Medical Robot in China
Financings of Major Medical Robot Companies in China, 2013-2020
Revenue and Net Income of Intuitive Surgical, 2010-2020
Global Placement of da Vinci Surgical System (by Region) by the End of Mar.31, 2020
Number of Surgeries Operated by da Vinci Surgical System (by Type), 2014-2019
System Placements and Installed Base of da Vinci Surgical System of Intuitive by Region, 2017-2019
Development of Intuitive in Germany and Japan, 2008-2019
Commercialization of Da Vinci Surgical Systems
Revenue of Intuitive Surgical (by Product), 2012-2019
Revenue of Intuitive Surgical (by Type), 2017-2019
Revenue of Intuitive Surgical (by Region), 2017-2019
Gross Margin of Intuitive Surgical, 2010-2019
R&D Cost and % of Total Revenue of Intuitive Surgical, 2012-2019
Revenue and Net Income of Stryker, 2015-2020
Revenue of Stryker by Product, 2015-2020
Orthopaedics Business’s Revenue Breakdown of Stryker by Application, 2015-2020
MedSurg Business’s Revenue Breakdown of Stryker by Application, 2015-2020
Neurotechnology and Spine Business’s Revenue Breakdown of Stryker by Application, 2015-2020
Gross Margin of Stryker, 2015-2020
R&D Costs and % of Total Revenue of Stryker, 2015-2020
Knee-joint and Hip-joint Systems of Makoplasty
Revenue of Ekso Bionics, 2015-2020
Net Income of Ekso Bionics, 2015-2020
Revenue of Ekso Bionics by Product, 2016-2020
Gross Margin of Ekso Bionics, 2015-2020
R&D Costs and % of Total Revenue of Ekso Bionics, 2015-2020
Revenue of Rewalk Robotics, 2015-2020
Net Income of Rewalk Robotics, 2015-2020
Revenue of Rewalk Robotics by Region, 2015-2020
Gross Margin of Rewalk Robotics, 2015-2020
R&D Costs and % of Total Revenue of Rewalk Robotics, 2015-2020
Global Operations of Rex Bionics
Revenue of Mazor, 2011-2018
Net Income of Mazor, 2011-2018
Revenue Structure of Mazor (by Business), 2010-2017
Products of Mazor (by Regional Installations), 2010-2016
Gross Margin of Mazor (by Business), 2011-2018
R&D Costs and % of Total Revenue of Mazor, 2011-2018
Revenue and Net Income of Johnson & Johnson, 2015-2020
Revenue of Johnson & Johnson by Product, 2015-2020
Medical Devices Business’s Revenue of Johnson & Johnson by Application, 2015-2020
Gross Margin of Johnson & Johnson, 2015-2020
R&D Costs and % of Total Revenue of Johnson & Johnson, 2015-2020
Laparoscopic Operation Robots of Avatera
Versius Surgical Robotic System of CMR Surgical
Flex Robotic System of Medrobotics
Achievements of Medtronic, 2015-2019
Revenue Breakdown of Medtronic (by Business), 2018-2019
MAZOR X STEALTH EDITION
Achievements of Meerecompany, 2017-2019
Revo-I Vision cart
Revo-I Operation cart
Revo-I Surgeon console
Achievements of Titan Medical, 2018-2019
Achievements of TransEnterix, 2018-2019 ($ in thousand)
The Senhance Surgical System
Operation of SIASUN’s Major Subsidiaries, 2019
Revenue and Net Income of SIASUN, 2015-2020
Revenue of SIASUN by Product, 2015-2019
Operating Revenue of SIASUN by Region, 2015-2019
Gross Margin of SIASUN by Product, 2015-2019
Revenue and Gross Profit of SIASUN’s Industrial Robot Business, 2015-2019
Revenue and Net Income of Jinming Machinery, 2015-2020
Gross Margin of Jinming Machinery, 2015-2020
Revenue of Jinming Machinery by Product, 2015-2019
Research Direction of Jinming Machinery and Tsinghua University’s Joint Research Center
Revenue and Net Income of Midea Group, 2015-2020
Gross Margin of Midea Group, 2015-2020
Revenue of Midea Group by Product, 2016-2019
Midea’s Subsidiaries Involving Robotics Business
Revenue and Net Income of Truking Technology, 2015-2020
Gross Margin of Truking Technology, 2015-2020
Revenue of Truking Technology by Product, 2015-2019
Revenue and Net Income of Dima Industry, 2010-2020
Gross Margin of Dima Industry, 2010-2020
Revenue of Dima Industry by Product, 2010-2019
Global Presence of Mai Kangxin
Northwestern Network of Mai Kangxin
Revenue and Net Income of Beijing TINAVI Medical Technology, 2013-2020
Operating Revenue Structure of Beijing TINAVI Medical Technology (by Product), 2017-2019
Operating Revenue Structure of Beijing TINAVI Medical Technology (by Region), 2017-2019
Capacity, Output and Sales Volume of Orthopedic Surgery Navigation and Positioning Robot of Beijing TINAVI Medical Technology, 2017-2019
Orthopedic Surgery Navigation and Positioning Robot Revenue (by Sales Model) of Beijing TINAVI Medical Technology, 2017-2019
Averaging Selling Price of Orthopedic Surgery Navigation and Positioning Robot (by Model) of Beijing TINAVI Medical Technology, 2017-2019
Revenue and Net Income of Boshi Automation, 2011-2020
Gross Margin of Boshi Automation, 2011-2020
Revenue of Boshi Automation by Product, 2011-2019
Distribution of Remebot’s Cooperative Hospitals
Hospitals that Have Conducted ‘Remebot’-assisted DBS Surgery in China
Medical Robot Products of Jinshan Science & Technology
Development History of Taimi Robotics Technology
Medical Robots of Taimi Robotics Technology
Development History of ANKON Technologies
Revenue and Net Income of ANKON Technologies, 2016-2018
Gross Margin of ANKON Technologies, 2016-2018
Operating Revenue of ANKON Technologies by Product, 2016-2018
Output, Sales and Capacity of ANKON Technologies, 2016-2018
Unit Price and Sales Volume of Main Productsof ANKON Technologies, 2016-2018
Partners of ANKON Technologies
Revenue Contribution and % of Total of ANKON Technologies’ Top 5 Customers, 2016-2018
Development History of Shenzhen Weibond Technology
Intelligent Intravenous Admixture Service Robots of Shenzhen Weibond Technology
Development History of Shenzhen Sanggu Technology
Intravenous Admixture Service Robots of Shenzhen Sanggu Technology
Development History of Wuxi Anzhizhuo Medical Robot
Medical Robots of Wuxi Anzhizhuo Medical Robot
China Blood Product Industry Report, 2020-2027
With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...
China Medical Robot Industry Report, 2020-2026
Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...
China In Vitro Diagnostic (IVD) Industry Report, 2019-2025
In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...
China Aged Care Industry Report, 2019-2025
China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...
China Dental Industry Report, 2019-2025
Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...
China Hospital Industry Report,2019-2025
The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...
China Dental Industry Report, 2017-2021
As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...
China Interferon Industry Report, 2016-2021
Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...
China Hospital Industry Report,2016-2020
In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...
China Aged Care Industry Report, 2016-2020
China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...
China Medical Robotics Industry Report, 2016-2020
Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...
China Dental Industry Report, 2016-2020
The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...
China Medical Imaging Diagnosis Industry Report, 2015-2019
Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...
China Heparin Industry Report, 2015-2018
As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...
Global and China Stem Cell Industry Report, 2015-2018
Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...
China Hospital Industry Report, 2015-2018
Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...
China Independent Clinical Laboratory Industry Report, 2015-2018
The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...
China Medical Robot Industry Report, 2014-2018
Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments.
Due to ...